NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3)
| קרן | National Institute on Drug Abuse/NIH |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 25/07/2020 |
| פקולטה | Life Sciences, Medicine, Social Sciences |
| תיאור | The purpose of this award is to support outstanding basic and/or clinical researchers with the vision and expertise to translate research discoveries into medications for the treatment of Substance Use Disorders (SUDs) stemming from tobacco, cannabis, cocaine, methamphetamine, heroin, or prescription opiate use.
Funding: $1,000,000 per year Duration: UG3 2 years; UH3 3 years
Research Authority due dates: 10 days prior to submission LOI (encouraged) due date: 25.6.18, 25.6.19, 25.6.20 Full proposal due dates: 25.7.18, 25.7.19, 25.9.20 |
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 29/01/2018 |
